focus -WSS

focus

author：fashion 2025-10-02 00:43:03 - browse：375

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Shingles, which affected Dianne Feinstein, is on the rise

focus

WSS

Nurses recount patients attacks

Gene editing the human germline: What are the risks?

Stop the failed accountable care organization experiment

Mindstrong's demise and the future of mental health care

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Cigna to pay $172 million to settle Medicare Advantage fraud probe

entertainment

focus

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicaid, Medicare dual

Virginia high school admissions case could be legal follow

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Guidelines to prevent youth baseball injuries need more muscle

U.K. researchers warn about biases in medical devices, algorithms

BioMarin wins approval for gene therapy to treat hemophilia A

Mindstrong's demise and the future of mental health care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Paxlovid should be available without a positive Covid test

knowledge

Inequities make cancer less preventable for women: report

Kaiser Permanente unions announce official strike date

Medicare drug price negotiation program allowed for now

UnitedHealth increases loan offers after Change Healthcare outage

Inequities make cancer less preventable for women: report

Health tech startups drop sharply from 2021 highs

leisure time

explore

focus

leisure time